NAPRA releases final brimonidine tartrate ophthalmic solution recommendationsThe National Association of Pharmacy Regulatory Authorities has finalized its recommendations on on brimonidine tartrate ophthalmic solution in concentrations up to and Including 0.025%. The eight most important NAPRA moves of 2021The organization's annual report for 2021, Navigating a World in Transition, covers the key moves for last year, as well as what's coming up in the rest of 2022. PEI pharmacists gain minor ailment prescribing, ability to renew prescriptions The Pharmacy Plus PEI program allows pharmacists to assess and prescribe for 32 common ailments as well as renewing prescriptions. First Previous 16 17 18
